Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
A rare Ebola relative called Bundibugyo virus is fueling a major outbreak in the DRC and Uganda, exposing critical gaps in global outbreak preparedness. With no licensed vaccine or treatment, limited lab access, and symptoms that mimic common illnesses, containing the virus is a serious challenge. Experts say the world needs to prepare for rare pathogens — not just the familiar ones.
A growing outbreak of Bundibugyo virus — a rare but deadly relative of Ebola — is spreading across the Democratic Republic of Congo and Uganda, shining a harsh light on how unprepared the world is for pathogens that fly under the radar. In a review published in the New England Journal of Medicine, Boston University virologist Nancy Sullivan argues that global preparedness strategies are too narrowly focused on well-known threats, leaving dangerous gaps when rare viruses resurface.
Bundibugyo causes severe hemorrhagic fever, triggering widespread inflammation, vascular damage, uncontrolled bleeding, and multi-organ failure. It spreads through contact with infected bodily fluids, putting family members, caregivers, and healthcare workers at particular risk. Its early symptoms closely mimic malaria and typhoid fever, making rapid lab confirmation essential — but lab access in affected regions is severely limited, with samples sometimes traveling long distances to reach national reference laboratories.
By the Numbers:
Why it matters: Bundibugyo's resurgence is a wake-up call that the next deadly outbreak may not come from the pathogens we're already watching. Sullivan warns that preparedness must go beyond diagnostics and vaccines to include "operational readiness for multinational outbreak response" — because rare viruses don't wait for the world to catch up.
